As part of the preclinical development plan, we require the development and validation of a bioanalytical method to perform bioanalysis of toxicological programme supporting a first-in-human clinical study with nano-GLA.
This RFQ is issued to select the most suitable service provider for the validation of an analytical method called “Method Development of an ELISA Method for the Determination of Anti-GLA Antibodies in Rat Plasma”
All quotations must be submitted by [24/09/2025, 23:59 CET] to: [info@delbios.com]
Subject: RFQ-TOX-001-2025